Opendata, web and dolomites

SINUSHUNT SIGNED

SinuShunt – New disruptive medical device for treatment of hydrocephalus

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SINUSHUNT project word cloud

Explore the words cloud of the SINUSHUNT project. It provides you a very rough idea of what is the project "SINUSHUNT" about.

diagnostic    infections    natural    2b    central    neurological    normal    hunt    people    blockage    aging    centrally    untreated    either    shunt    population    inefficiency    life    device    significantly    csf    close    quality    112    caused    patients    obstruction    additional    implantation    steadily    failing    drainage    innovation    employ    placed    fluid    shunting    devastating    abdomen    medical    stent    valued    thereof    6b    sinushunt    lot    time    solution    internationally    endoscope    resorption    chest    period    uses    patient    cerebrospinal    place    operations    5b    avoiding    brain    incl    surgical    implantable    re    brings    industry    tools    reducing    treatment    disruptive    annually    draining    sinus    cagr    amount    2023    care    conventional    option    constantly    2026    hydrocephalus    propelled    neurosurgeons    complications    vein    1950s    substance    health    market    outlet    instead    fatal    sell    roi    shunts       accumulation    dynamics    advantages    competitive    left   

Project "SINUSHUNT" data sheet

The following table provides information about the project.

Coordinator
CSF-DYNAMICS A/S 

Organization address
address: GAMMEL LUNDTOFTEVEJ 1 D
city: KGS. LYNGBY
postcode: 2800
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Denmark [DK]
 Total cost 998˙375 €
 EC max contribution 698˙862 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-02-01   to  2021-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CSF-DYNAMICS A/S DK (KGS. LYNGBY) coordinator 698˙862.00

Map

 Project objective

Hydrocephalus is a devastating neurological condition caused by accumulation of cerebrospinal fluid (CSF) on brain, and If left untreated, it can be fatal. The only treatment option is surgical, either implantation of a shunting device placed centrally in the brain, or, in some cases, by use of an endoscope going through the brain substance to its central part. The main problem in the industry is that conventional treatment systems (shunts) are based on a technology from 1950s and they are failing on average in 4-8 years, due to blockage or over-drainage. This results in 100 000 re-operations annually and brings a lot of complications (incl. increased infections) to the patient. Furthermore, this inefficiency represents an additional cost of €1.5B for the health care systems annually. To offer a solution to these problems, CSF-Dynamics is developing a new disruptive implantable medical device for treatment of hydrocephalus. The main innovation is draining the cerebrospinal fluid into sinus vein that is a natural resorption place of CSF, instead of conventional chest or abdomen. The hunt system uses novel stent technology as an outlet into the sinus vein, to avoid obstruction. SinuShunt competitive advantages are: 1) significantly increased life-time of the shunt, therefore reducing amount of re-operations; 2) Better quality of life for the patient due to the close to normal drainage of the brain-fluid, avoiding over-drainage and complications thereof. Hydrocephalus market is currently valued at €1.2B and is expected to reach a value of €1.6B by 2023. The market is steadily growing at CAGR of 4.4% during this time period. The market growth is propelled by growth in aging of population, increasing awareness of the condition and constantly improving diagnostic tools. Our end-users are hydrocephalus patients and users neurosurgeons. By 2026 we expect to sell our solution internationally, employ additional 112 people, and achieve a ROI of 40.6.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SINUSHUNT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SINUSHUNT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

LIVELMIA (2019)

Innovative assay for microRNAs analysis

Read More  

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More  

IMPACT (2019)

Improving DNA Analysis for Correct Healthcare

Read More